AMF Tjanstepension AB Grows Stake in Intuitive Surgical, Inc. $ISRG

AMF Tjanstepension AB grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 120.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 147,796 shares of the medical equipment provider’s stock after purchasing an additional 80,873 shares during the period. AMF Tjanstepension AB’s holdings in Intuitive Surgical were worth $80,314,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Aaron Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after buying an additional 19 shares during the period. Crown Wealth Group LLC increased its position in shares of Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock valued at $218,000 after buying an additional 20 shares during the period. FSM Wealth Advisors LLC increased its position in shares of Intuitive Surgical by 3.8% during the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock valued at $270,000 after buying an additional 20 shares during the period. CFO4Life Group LLC increased its position in shares of Intuitive Surgical by 4.8% during the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock valued at $216,000 after buying an additional 20 shares during the period. Finally, J. W. Coons Advisors LLC increased its position in shares of Intuitive Surgical by 1.4% during the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after buying an additional 20 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 2.1%

NASDAQ:ISRG opened at $452.35 on Friday. The company’s 50 day moving average price is $463.55 and its 200-day moving average price is $500.00. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The stock has a market cap of $162.16 billion, a price-to-earnings ratio of 63.09, a PEG ratio of 4.64 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating analysts’ consensus estimates of $1.93 by $0.26. The firm had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue for the quarter was up 21.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.78 earnings per share. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares in the company, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Amy L. Ladd sold 336 shares of the stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 over the last quarter. Company insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

ISRG has been the topic of several research analyst reports. Evercore ISI boosted their price target on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research report on Tuesday, July 8th. The Goldman Sachs Group reduced their price target on shares of Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating on the stock in a research report on Wednesday. Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Wednesday, August 20th. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a report on Saturday, September 27th. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $594.19.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.